Inhibition of human platelet aggregation by diazeniumdiolates: Extent of inhibition correlates with nitric oxide load delivered

被引:9
|
作者
Raulli, R [1 ]
机构
[1] Amer Red Cross, Jerome H Holland Lab, Cell Biol Lab, Rockville, MD 20853 USA
关键词
D O I
10.1111/j.2042-7158.1998.tb03308.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The profile of nitric oxide (NO) release from the diazeniumdiolate class of NO donors was evaluated using inhibition of platelet aggregation as a model. At 37 degrees C, the NO complexes (Z)-1-{N-methyl-N-[6-(N-methylammoniohexyl)amino]}-diazen-1-ium-1,2-diolate (dimethylhexanediamine complex), sodium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-diolate (diethylamine complex), (Z)-1-{N-[3-aminopropyl]-N-[4-(3-aminopropylammonio)butyl]amino}diazeb-1-ium-1,2-diolate (spermine complex), and (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate (diethylene-triamine complex) have half-lives of 1, 2 and 39 min, and 20 h, respectively. All the diazeniumdiolates caused concentration-dependent inhibition of platelet aggregation; IC50 values (values for which the effect was half the maximum) were 26.0+/-24.1, 34.9+/-24.0 and 14.9+/-6.4 nM for dimethylhexanediamine complex, diethylamine complex and spermine complex, respectively, when pre-incubated with platelets for one half-life. Inhibition by all compounds was time-dependent. Pretreatment of platelets with spermine complex for 5 and 39 min resulted in IC50 values of 1.7+/-0.85 mu M and 19.7+/-0.12 nM, whereas IC50 values for sodium nitroprusside were 27.3+/-1.25 nM and 25 nM (average, n = 2), at 5 and 39 min, respectively. Pre-incubation of each diazeniumdiolate at a concentration of 100 nM for 5 min at 37 degrees C, which resulted in the theoretical delivery of NO loads from 96.9% down to 0.3%, resulted in decreasingly efficacious inhibition of platelet aggregation. Linear regression analysis of the theoretical NO load delivered against the actual maximum inhibition (%) showed a strong correlation (r(2) = 0.975). All four diazeniumdiolates caused concentration-and time-dependent inhibition of agonist-stimulated elevation of intra-platelet Ca2+ levels; IC50 values were, respectively, 8.7+/-1.49 nM and 11.5+/-1.36 nM for dimethylhexanediamine complex and diethylamine complex at their half-lives, and 176+/-16.9 nM and > 100 mu M, for spermine complex and diethylenetriamine complex at 2 min pre-incubation time. The respective nucleophiles not complexed with NO did not show anti-aggregatory properties or inhibition of agonist-induced elevation of intraplatelet Ca2+ levels. The inhibitory effects of all diazeniumdiolates tested were attenuated by 10 mu M haemoglobin. These studies indicate that these compounds induce controlled, predictable release of NO at biological pH and temperature.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 50 条
  • [21] ADENOSINE INHIBITION OF HUMAN PLATELET AGGREGATION BY ADP
    CAEN, JP
    BELLANGER, R
    JENKINS, CSP
    MICHEL, H
    NATURE-NEW BIOLOGY, 1972, 239 (94): : 211 - +
  • [22] INHIBITION OF HUMAN-PLATELET AGGREGATION BY DDT
    CRUMP, D
    GWEBU, ET
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 677 - 677
  • [23] INHIBITION OF COLLAGEN INDUCED HUMAN PLATELET AGGREGATION
    HERRMANN, RG
    CROWE, VG
    LACEFIELD, WB
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1972, 196 (02): : 316 - +
  • [24] DIFFERENTIAL INHIBITION OF PLATELET-AGGREGATION AND CALCIUM MOBILIZATION BY NITROGLYCERIN AND STABILIZED NITRIC-OXIDE
    AMANO, M
    TAKAHASHI, M
    KOSAKA, T
    KINOSHITA, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 24 (06) : 860 - 866
  • [25] Nitric oxide inhibition enhances platelet aggregation in experimental anti-Thy-1 nephritis
    van Goor, H
    Albrecht, EWJA
    Heeringa, P
    Klok, PA
    van der Horst, MLC
    de Jager-Krikken, A
    Bakker, WW
    Moshage, H
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2001, 5 (06): : 525 - 533
  • [26] Inhibition of platelet aggregation
    Wascher, Thomas C.
    WIENER KLINISCHE WOCHENSCHRIFT, 2007, 119 : 26 - 26
  • [27] Inhibition of Platelet Aggregation
    Wascher, Thomas
    WIENER KLINISCHE WOCHENSCHRIFT, 2012, 124 : 31 - 32
  • [28] Inhibition of platelet aggregation
    Wascher, TC
    ACTA MEDICA AUSTRIACA, 2004, 31 (05) : 170 - 170
  • [29] Inhibition of platelet aggregation
    Wascher, Thomas C.
    Saely, Christoph H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S71 - S72
  • [30] Inhibition of platelet aggregation
    Wascher, Thomas C.
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 : S28 - S29